SCHEDULE: FMR LLC Discloses 5% Stake in Revolution Medicines

FMR LLC and Abigail P. Johnson have reported a 5.0% beneficial ownership stake in Revolution Medicines Inc. common stock as of September 30, 2025.

Summary

• FMR LLC and Abigail P. Johnson collectively beneficially own 9,401,686.70 shares of Revolution Medicines Inc. common stock.
• This ownership represents 5.0% of the company's total outstanding common stock.
• The filing is made under Rule 13d-1(b), indicating a passive investment without the intent to influence control over the issuer.
• FMR LLC holds sole voting power over 9,391,589.00 shares and sole dispositive power over 9,401,686.70 shares.
• Abigail P. Johnson, as a control person of FMR LLC, is also deemed to beneficially own the same 9,401,686.70 shares with sole dispositive power.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of beneficial ownership by a major institutional investor, FMR LLC, and its principal, Abigail P. Johnson. The 5.0% stake indicates a significant, passive investment in Revolution Medicines Inc., which can be viewed as a vote of confidence without implying any active strategic involvement or performance assessment.

Positives

• FMR LLC, a major institutional investor, has disclosed a 5.0% beneficial ownership stake in Revolution Medicines Inc., signaling significant institutional interest in the company.

Future Outlook

NA

Industry Context

This filing indicates a significant passive investment by a major asset manager in a biotechnology or pharmaceutical company, which is a common occurrence in the sector as institutional funds build positions in promising firms.

Stakeholder Impact

• Shareholders: The disclosure of a 5% stake by a prominent institutional investor like FMR LLC may instill confidence and potentially attract further institutional interest, positively impacting share liquidity and valuation perception.

Key Dates

Recommendation

The filing reports a significant, passive 5.0% ownership stake by FMR LLC, a prominent institutional investor. This indicates institutional confidence in Revolution Medicines Inc. without suggesting any immediate operational changes or performance catalysts. Therefore, a 'Hold' recommendation is appropriate, acknowledging the positive signal of institutional interest.

Keywords

Revolution Medicines Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Biotechnology, Pharmaceuticals